Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-03-2024 | Ivermectin | Case report

Albendazole/dexamethasone/ivermectin

Disseminated strongyloidiasis and lack of efficacy

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Garcia SN, et al. A Case of Severe Disseminated Strongyloidiasis With Confirmed Diagnosis by Skin Biopsy, Small Bowel Biopsy and Bronchoalveolar Lavage. American Journal of Respiratory and Critical Care Medicine 207: Jan 2023. Available from: URL: https://dx.doi.org/10.1164/ajrccm-conference.2023.C105 [abstract] Garcia SN, et al. A Case of Severe Disseminated Strongyloidiasis With Confirmed Diagnosis by Skin Biopsy, Small Bowel Biopsy and Bronchoalveolar Lavage. American Journal of Respiratory and Critical Care Medicine 207: Jan 2023. Available from: URL: https://dx.doi.org/10.1164/ajrccm-conference.2023.C105 [abstract]
Metadata
Title
Albendazole/dexamethasone/ivermectin
Disseminated strongyloidiasis and lack of efficacy
Publication date
01-03-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-54332-5

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Tacrolimus

Case report

Denosumab

Case report

Tofersen

Case report

Rituximab